Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Dermisonics Inc

+ Add to Watchlist

DMSI:US

0.0023 USD 0.0001 4.55%

As of 20:10:01 ET on 03/26/2015.

Snapshot for Dermisonics Inc (DMSI)

Open: 0.0023 Day's Range: 0.0023 - 0.0023 Volume: 4,500
Previous Close: 0.0022 52wk Range: 0.0012 - 0.0150 1-Yr Rtn: +8.24%

Stock Chart for DMSI

No chart data available.
  • DMSI:US 0.0023
  • 1D
  • 1M
  • 1Y
0.0022
Interactive DMSI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DMSI

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.2200
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.23
Shares Outstanding (M) 100.00
30 Day Average Volume 1,671
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DMSI

No data available

Company Profile & Key Executives for DMSI

Dermisonics, Inc. is a development stage biotechnology company focused on the development, testing, and commercialization of a transdermal patch. The Company's product has been designed to facilitate the efficient and needle-free delivery of heavy molecular drugs into the system.

Bruce H HaglundChairman/Interim CEO & CFOBruce K ReddingVP:Licensing & Corp Strategy
More Company Profile & Key Executives for DMSI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil